Dose-dense epirubicin and cyclophosphamide followed by docetaxel as adjuvant chemotherapy in node-positive breast cancer.

Autor: Mirzaei HR; Department of Radiation & Oncology, Cancer Research Center, Shohadaye-Tajrish Hospital of Shahid Beheshti University of Medical Sciences and Health Services, Tajrish Square, Tehran, Iran., Sabet Rasekh P, Nasrollahi F, Sabet Rasekh P, Akbari Tirabad Z, Moein HR, Ghaffari Pour T, Hajian P

Publikováno v: International journal of breast cancer [Int J Breast Cancer] 2013; Vol. 2013, pp. 404396. Date of Electronic Publication: 2013 Sep 25.